BiopharmX vs Neothetics vs Galena

1 Mio Aktien gehandelt. Sollte morgen in der 1 Handelsstunde weiterlaufen

Schaut auf die Performance der letzten Tage und letzte News, Power on!!!

Auf geile Trades

für eine Reaktion.... wurde alles besprochen.... jetzt ist warten angesagt... bin schon gut positioniert aber stehe auch nochmal tiefer bereit....  

Dir die Frage nicht beantworten....sonst ist hier z.Z. ja auch nicht viel los, denke das niemand hier die Frage beantworten kann...  

interessieren

Absoluter Totentanz

„The special meeting of stockholders of Neothetics will be held on January 5, 2018 at 8:00 a.m., local time, at the offices of DLA Piper LLP (US) located at 4365 Executive Drive, Suite 1100, San Diego, CA 92121“

http://www.conferencecalltranscripts.org/no/summary2/?id=4400092

Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“

„The special meeting of stockholders of Neothetics will be held on January 5, 2018 at 8:00 a.m., local time, at the offices of DLA Piper LLP (US) located at 4365 Executive Drive, Suite 1100, San Diego, CA 92121“



www.conferencecalltranscripts.org/no/summary2/?id=4400092



Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“

0,15, ziel 0,19

Hat jemand einenLink oder Infos zu dieser Explosion? Was sind hier die Kurstreiber? Danke

www.reddit.com/r/RobinHoodPennyStocks/...ch_rumors_and_mores/

1.) Annual ROTH Conference Date: March 11st 2018

The ROTH Conference is basically a dick showing contest. 550 companies come from around the world and showcase their company and products. This should be great exposure for BPMX and if I am a betting man after the conference we will see higher volume and maybe a price jump.

2.) BPMX announces their earnings and possible FDA approval Date: March 22nd 2018

3.) Completion of BPX-01 and BPX-04, clinical trials Date: June 2018

www.sec.gov/Archives/edgar/data/885725/...2018creditagree.htm

www.prnewswire.com/news-releases/...tock-split-300831591.html

www.rttnews.com/3009709/...s-primary-secondary-endpoints.aspx

• vorbörslich aktuell bei 0,61$ (-15%)
  
• geringe Cashreichweite
  

biopharmx.investorroom.com/...X-04-for-Papulopustular-Rosacea

biopharmx.investorroom.com/...-Quarter-2020-Financial-Results